View Risk


Article data
Zhang (2020)
Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China
https://doi.org/10.1016/j.annonc.2020.03.296
https://www.sciencedirect.com/science/article/pii/S0923753420363833

Results
Treatment
Concomitant medication (Anti-tumor treatment <=14 days before COVID-19 diagnosis vs. Anti-tumor treatment >14 days before COVID-19 diagnosis)
COVID-19 (severe/fatal)
Hazard ratio: 4.080 (1.090-15.320) Adjusted model. Calculated odds ratio based on data reported in the article.

Study characteristics

China

Retrospective cohort study

Medical records

28

Hospitalized cancer patients diagnosed with COVID-19 infection

Median age is 65 years old. 17 (60.7%) are males

Median

7 Day


Results

COVID-19 (severe/fatal)

15

Patients with condition leading to admission to an Intensive Care Unit (ICU), the use of mechanical ventilation, or death

Treatment

Concomitant medication

none

Anti-tumor treatment >14 days before COVID-19 diagnosis

10

22

Anti-tumor treatment <=14 days before COVID-19 diagnosis

5

6

Hazard ratio

4.080 (1.090-15.320)

No

Yes

Yes

risk was adjusted for age and gender


Other information

The low sample size (n=28) could have limited statistical power.

Average

Yes

Go Back